Greenwich Lifesciences Inc (GLSI)
$15.95
$0.32
(2.05%)
As on 04-Sep-2026 16:00EDT
Market cap
$234 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
70.7
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-9.9 %
-
ROCE
-- %
-
Industry P/E
37.91
-
EV/EBITDA
-21.2
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-1.5
-
Face value
--
-
Shares outstanding
14,678,208
6 Years Aggregate
CFO
$-18.53 Mln
EBITDA
$-28.92 Mln
Net Profit
$-28.02 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Greenwich Lifesciences Inc (GLSI)
| -24.1 | 17.8 | -34.3 | 38.3 | 20.0 | -18.3 | -- |
|
BSE Sensex*
| -10.7 | -3.7 | 1.8 | -6.3 | 4.5 | 5.3 | 10.1 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
|---|---|---|---|---|---|
|
Greenwich Lifesciences Inc (GLSI)
| 87.1 | 6.7 | -30.8 | -37.5 | -33.3 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Greenwich Lifesciences Inc (GLSI)
|
16.0 | 234.1 | 0.0 | -21.7 | 94,986.2 | -1249.5 | -- | 70.7 |
| 17.4 | 6,074.3 | 3,117.6 | 157.4 | 14.7 | -- | 36.3 | 188.5 | |
| 206.7 | 10,826.1 | 776.6 | -191.6 | -17.6 | -223.4 | -- | 131.0 | |
| 74.8 | 14,630.7 | 691.8 | -696.2 | -89.1 | -- | -- | 123.7 | |
| 111.6 | 12,065.9 | 830.8 | 54.9 | 3.2 | 8.1 | 248 | 17.3 | |
| 12.0 | 10,020.9 | 332,834.2 | 33,166.6 | 11.1 | 8.9 | 29.3 | 2.5 | |
| 24.5 | 12,236.5 | 5,020.0 | -199.0 | 1.6 | -3 | -- | 1.9 | |
| 285.6 | 5,693.6 | 290.5 | 197.2 | 82.5 | 19.9 | 29.8 | 5.9 | |
| 68.7 | 6,145.7 | 450.9 | 138.6 | 39.1 | 115.6 | 49 | 30.7 | |
| 124.7 | 8,210.6 | 431.8 | -136.7 | -30.8 | -30.3 | -- | 19.0 |
Shareholding Pattern
View DetailsAbout Greenwich Lifesciences Inc (GLSI)
Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers in the United States. Its lead product candidate is GP2, a HER2/neu transmembrane... peptide, which is in Phase III clinical trial to prevent breast cancer recurrences in patients. The company also develops FLAMINGO-01, which is in Phase IIb and 3 Phase I clinical trial designed to evaluate the safety and efficacy of GLSI-100 in HER2 positive breast cancer patients. Greenwich LifeSciences, Inc. was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. The company was incorporated in 2006 and is headquartered in Stafford, Texas. Read more
-
CEO, CFO & Director
Mr. Snehal S. Patel
-
CEO, CFO & Director
Mr. Snehal S. Patel
-
Headquarters
Stafford, TX
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Greenwich Lifesciences Inc (GLSI)
What is the current share price of Greenwich Lifesciences Inc (GLSI) Today?
The share price of Greenwich Lifesciences Inc (GLSI) is $15.95 (NASDAQ) as of 04-Sep-2026 16:00 EDT. Greenwich Lifesciences Inc (GLSI) has given a return of 20% in the last 3 years.
What is the current PB & PE ratio of Greenwich Lifesciences Inc (GLSI)?
Since, TTM earnings of Greenwich Lifesciences Inc (GLSI) is negative, P/E ratio is not available.
The P/B ratio of Greenwich Lifesciences Inc (GLSI) is 70.71 times as on 04-Sep-2026, a 820 premium to its peers’ median range of 7.69 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-15.52 |
850.50 |
2024 |
-8.48 |
162.56 |
2023 |
-15.20 |
20.17 |
2022 |
-24.56 |
14.55 |
2021 |
-68.65 |
11.69 |
What is the 52 Week High and Low of Greenwich Lifesciences Inc (GLSI)?
The 52-week high and low of Greenwich Lifesciences Inc (GLSI) are Rs 34.10 and Rs 7.78 as of 08-Sep-2026.
What is the market cap of Greenwich Lifesciences Inc (GLSI)?
Greenwich Lifesciences Inc (GLSI) has a market capitalisation of $ 234 Mln as on 04-Sep-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Greenwich Lifesciences Inc (GLSI)?
Before investing in Greenwich Lifesciences Inc (GLSI), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.